Display Settings:

Format

Send to:

Choose Destination
    J Am Coll Cardiol. 2010 Jan 12;55(2):97-101.

    Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements.

    Source

    Sussex Cardiac Centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK. drzeeshan@doctors.org.uk

    Abstract

    Transcatheter aortic valve implantation is increasingly being used to treat severe aortic stenosis in patients with high operative risk. In an aging population the incidence of aortic stenosis is rising, and increasing numbers of elderly patients are undergoing aortic valve replacement with bioprosthetic valves. Therefore, there is a corresponding increase in prosthetic degeneration. This presents cardiologists with a cohort of patients for whom the risk of re-do aortic valve surgery is prohibitive. We present the first series of such patients with degenerative bioprosthetic stenosis or regurgitation successfully treated with CoreValve (Medtronic, Luxembourg) implantation.

    PMID:
    20117377
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Elsevier Science Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk